Business Context and Reporting Period
This Form 8-K was filed by The Chemours Company on July 23, 2024. The report discloses the appointment of a new Controller and Chief Accounting Officer, effective August 12, 2024.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change is the appointment of David A. Will as Controller and Chief Accounting Officer. Shane Hostetter, the current Chief Financial Officer, will continue to serve as principal accounting officer until Mr. Will's appointment becomes effective.
Management Commentary and Compensation Details
Mr. Will, age 40, brings experience from Copeland LP and Quaker Chemical Corporation. His compensation package includes:
- Base Salary: $410,000 annually.
- Signing Bonus: $325,000.
- Annual Bonus: Target of 50% of base salary, prorated for the remainder of 2024.
- Long-Term Incentive (LTI): Target award opportunity of $300,000.
- Restricted Stock Units (RSUs): A one-time grant valued at $125,000 for 2024 service and an additional grant valued at $250,000 to offset lost opportunities from his prior employer. These RSUs vest one-third per year over three years.
- One-Time Cash Payment: $150,000 to be paid in March 2025 to offset lost stock option vesting and bonus opportunities.
Investor Verification Checklist
- Confirm the effective date of David A. Will's appointment (August 12, 2024).
- Verify the total value of the compensation package, including the $325,000 signing bonus and $150,000 deferred cash payment.
- Review the vesting schedule for the $375,000 total RSU grant ($125,000 + $250,000).
- Ensure no undisclosed family relationships or transactions exist between Mr. Will and other company officers.